Product

BT524

Aliases

Human Fibrinogen concentrate

1 clinical trial

2 indications

Indication

Bleeding Disorder

Indication

Hypofibrinogenemia

Clinical trial

A Randomized, Active-controlled, Multicenter, Phase III Study Investigating Efficacy and Safety of Intra-operative Use of BT524 (Human Fibrinogen Concentrate) in Subjects Undergoing Major Spinal or Abdominal Surgery (AdFIrst)

Status: Completed, Estimated PCD: 2023-09-25